Glaucium flavum
Glaucium flavum
Glaucium flavum, commonly known as yellow windpipe weasel or golden-glow, is a flowering plant traditionally found in Europe and parts of Asia. While its use in traditional medicine has not been extensively documented, studies have shown potential for various applications. Acteoside from Glaucium flavum has been identified as a neuroprotective agent that may inhibit α-synuclein aggregation and reduce oxidative stress, suggesting possible benefits in models of Parkinson's disease. Additionally, isoquinoline alkaloids found in the plant showed variability across different regions in Turkey and demonstrated anticholinesterase activities. Green synthesized gold nanoparticles using Glaucium flavum leaf extract exhibited effective antiviral and antioxidant properties with low cytotoxicity, indicating potential applications against viruses such as betacoronavirus HCoV-OC43 and dengue virus. No significant safety concerns or recorded drug interactions have been identified for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study identified acteoside from Glaucium flavum as a potential neuroprotective agent by inhibiting α-synuclein aggregation and reducing oxidative stress in models of Parkinson's disease.
- The study characterized isoquinoline alkaloids in Glaucium flavum from seven Turkish regions, identifying variability in major constituents and anticholinesterase activities.
- The study found that green synthesized gold nanoparticles using Glaucium flavum leaf extract showed effective antiviral and antioxidant activities with low cytotoxicity.
- Glaucium flavum showed potential antiviral activity against betacoronavirus HCoV-OC43 and dengue virus.
- The study reviewed chemistry and pharmacology of alkaloids from Glaucium species, noting anti-cancer and anti-cholinesterase effects.
Frequently asked questions
What is Glaucium flavum?
Glaucium flavum (Glaucium flavum) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Glaucium flavum?
5 sourced findings are recorded for Glaucium flavum; the strongest carries evidence grade D. For example: The study identified acteoside from Glaucium flavum as a potential neuroprotective agent by inhibiting α-synuclein aggregation and reducing oxidative stress in models of Parkinson's disease.
How strong is the evidence for Glaucium flavum?
The strongest finding for Glaucium flavum carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Glaucium flavum safe? What are the side effects?
No major safety issues are recorded for Glaucium flavum in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Glaucium flavum interact with medications?
No drug interactions are recorded for Glaucium flavum in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Glaucium flavum?
Glaucium flavum is also known as: Глауциум жёлтый, Glaucier jaune, Glaucière jaune, Pavot jaune des sables.
Is Glaucium flavum a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Phytochemistry and pharmacology of alkaloids from Glaucium spp. literature abstract metadata
- T2 Antiviral and antioxidant properties of green synthesized gold nanoparticles using Glaucium flavum leaf extract. literature abstract metadata
- T2 Biochemical Analyses of Bioactive Extracts from Plants Native to Lampedusa, Sicily Minor Island. literature abstract metadata
- T2 Variability of Isoquinoline Alkaloid Profiles and Anticholinesterase Activities with Binding-Mode Predictions of Glaucium flavum Population. literature abstract metadata
- T2 Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. literature abstract metadata